Detection and Clinical Implications of Circulating Tumor Cells in Cancer Patients
Klaus Pantel, Professor and Founding Director, University Of Hamburg
Detection and characterization of CTC opens a new avenue for
understanding metastatic spread of tumor cells with important
implications for future therapies. Implementation of CTC analyses in
clinical trials testing new anti-cancer agents as companion diagnostics
will speed up the cumbersome and expensive drug validation process in
oncology.
|
|